Medtronic Officer Files Intent to Sell $3.1M in MDT Stock
Medtronic plc
Subscribe to track MDT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Medtronic Officer Files Intent to Sell $3.1M in MDT Stock
Company: Medtronic plc (MDT) Form: 144 | Filed: 2025-11-19 Significance: Low
Insider: Smith Gregory L Title: Officer | Relationship: Officer
Transaction: • Type: Proposed Sale • Shares: 30,000 • Price: ~$101.95 • Value: $3,058,452 • Owned After: Not Disclosed
Key Insight: An officer has filed a notice of proposed sale for shares valued at approximately $3.1 million. The transaction size is negligible relative to Medtronic's $123B market cap.
Market Context: The sale represents a tiny fraction (0.0025%) of the company's market capitalization, indicating a routine liquidity event rather than a significant strategic move.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Medtronic plc (MDT)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of Medtronic has filed a notice of intent to sell 30,000 shares, a transaction valued at approximately $3.1 million. The sale's size is immaterial relative to the company's market capitalization.
- Market Impact: The transaction is unlikely to have any market impact due to its small size.
Company Information
| Field | Value |
|---|---|
| Company | Medtronic plc |
| Ticker Symbol | MDT |
| CIK | 0001613103 |
| Industry | Electromedical & Electrotherapeutic Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Smith Gregory L |
| CIK | 0001533098 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-19 |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 30,000 |
| Price Per Share | ~$101.95 (calculated) |
| Total Value | $3,058,452.26 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $3,058,452.26 |
| % of Market Cap | 0.0025% |
| Shares Transacted | 30,000 |
| % of Shares Outstanding | 0.0023% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Medtronic is a mega-cap company with a market capitalization of approximately $122.96 billion. A $3.1 million transaction is financially insignificant, representing a minuscule fraction of the company's total value.
- Transaction Significance: The sale constitutes just 0.0025% of the market cap and 0.0023% of shares outstanding, falling far below any threshold for material significance. Such sales are common for executives at large corporations for personal financial management.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is too small to signal any change in the insider's outlook or to affect market supply and demand dynamics for MDT stock.
Volume & Sentiment
- Expected Volume Impact: Negligible. The 30,000 shares are a tiny fraction of the typical daily trading volume for a stock of this size.
- Sentiment Indicator: Neutral. The sale is not indicative of a bearish outlook given its small scale and the origin of the shares (ESPP and vested RSUs), which often leads to periodic sales for liquidity and diversification.
Additional Context
Transaction Notes
- Nature of Filing: This Form 144 is a notice of a proposed sale, not a confirmation of a completed sale.
- Source of Shares: The filing indicates the shares to be sold were acquired through an Employee Stock Purchase Plan (ESPP) and the vesting of Restricted Stock Units (RSUs), which are standard forms of executive compensation.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
